Gozellix is now a fully reimbursed product in the U.S., having been granted a Level II HCPCS code 14 and TPT payment status (effective 1 October 2025) 15. Telix is the only company with two U.S. Food ...

Accelerate your tech game Paid Content How the New Space Race Will Drive Innovation How the metaverse will change the future of work and society Managing the ...

Background Triage and clinical consultations increasingly occur remotely. We aimed to learn why safety incidents occur in remote encounters and how to prevent them. Setting and sample UK primary care.

Square Enix released a trailer for Dragon Quest I & II HD-2D Remake earlier this week, showcasing a new underwater area known as the Seabed. Now, as part of its stage event at the Tokyo Game Show, ...

iTaperloc and iG7 integrate the clinical features of Zimmer Biomet’s Taperloc Complete Hip and the G7 Acetabular systems. Credit: JHVEPhoto / Shutterstock.com. Zimmer Biomet has secured approval from ...

NASA's Artemis II mission could happen as early as February. Here's why this flight will be one to watch. The Artemis II crew may be able to see parts of the moon humans haven’t experienced before; up ...

A sweeping change to the H-1B visa system could dramatically reshape who gets to work in the U.S.—and who doesn’t. Under a new wage-weighted lottery proposal set to take effect as early as FY2026, ...

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

aDepartment of Biostatistics and Epidemiology, Rutgers School of Public Health, New Brunswick, NJ, USA bDepartment of Health Behavior, Society and Policy, Rutgers School of Public Health, New ...

Positive announcement drives Telix Pharmaceuticals shares higher as the company secures U.S. CMS Transitional Pass-Through payment status for Gozellix, a breakthrough in its commercial strategy.

Telix Pharmaceuticals (ASX: TLX) is experiencing a resurgence in its share price, driven by strong financial results and key product approvals, despite facing regulatory challenges. The recent market ...